Keytruda

© Reuters. FILE PHOTO: The logo for Merck & Co. is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly/File Photo By Michael Erman (Reuters) -Merck…

IvelinRadkov The FDA has granted expanded approval for Merck’s (NYSE:MRK) oncology drug Keytruda in the treatment of non-small cell lung cancer, or NSCLC. Keytruda, also known as pembrolizumab, was approved as a neoadjuvant and…